Whilst further work is required to fully resolve these binding interfaces, the protein-protein interactions uncovered in these studies open up novel therapeutic options for targeting the discrete oncogenic JNK signaling complexes that regulate cancer stem cell populations in specific tumor types. Here, MAPK8 is linked to cancer.